By: Liza Laws
New cGMP fermentation facility in the UK set to meet growing demand for drug substance production, supporting biopharma manufacturing at scale.
Not enough data
Liza Laws predominantly covers the healthcare and pharmaceutical industry, with a focus on press releases and data-driven articles. Her coverage suggests she is likely to respond well to pitches centered around new medical research, drug development breakthroughs, innovative technology in healthcare, and advancements in clinical trials.
Given Liza's emphasis on citing data and private sector announcements, she may be particularly interested in pitches that offer exclusive access to new studies or insights into proprietary developments within the healthcare and pharmaceutical sectors.
It's important for potential sources reaching out to Liza to have credible expertise within these fields and possess compelling data or case studies that can support their pitch.
This information evolves through artificial intelligence and human feedback. Improve this profile .